Thomas Patrick Kelly, Chief Financial Officer at Deciphera Pharmaceuticals, Inc. (DCPH), sold 80,000 shares at $68.21 ($5.5M) on 2019-12-23, disclosed to the SEC on 2019-12-26.
Open-market sale of $5.5M DCPH by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $68.21 | 40,000 | $2.7M | 50.0% |
| 2 | $68.21 | 40,000 | $2.7M | 50.0% |
| Total | $68.21 avg | 80,000 | $5.5M | 100% |
| Filing → |
| DCPH | SELL | 2023-12-14 | $43K | — | Filing → |
| DCPH | SELL | 2023-10-31 | $28K | — | Filing → |
| DCPH | SELL | 2023-06-21 | $24K | — | Filing → |